Iatrogenic and toxic myopathies

Area of Science:

• Neurology
• Toxicology
• Cellular Biology

Background:

• Increasing awareness of adverse effects of therapeutic agents and exogenous toxins on muscle structure and function.
• Clinical syndromes range from myalgia to paralysis and myoglobinuria.
• Toxic myopathies are potentially reversible, emphasizing the need for prompt recognition.

Purpose of the Study:

• To highlight the clinical importance of toxic myopathies.
• To underscore their utility as experimental models in muscle research.
• To review the morphological and biochemical mechanisms of myotoxicity.

Main Methods:

• Review of existing literature on toxic myopathies.
• Analysis of morphological and biochemical studies.
• Categorization of muscle damage mechanisms induced by toxins.

Main Results:

• Toxins can induce various forms of muscle damage, including necrotizing, lysosomal-related, inflammatory, anti-microtubular, mitochondrial, hypokalemia-related, and protein synthesis-related.
• Understanding these mechanisms enhances knowledge of basic cellular processes in myotoxicity.
• Prompt diagnosis can mitigate damage and prevent fatal outcomes.

Conclusions:

• Toxic myopathies represent a significant clinical challenge with potentially reversible outcomes.
• They serve as valuable models for studying fundamental muscle biology and pathology.
• Further research into specific toxin-induced mechanisms can improve patient management and therapeutic strategies.